Re: Night shift work, light at night, and risk of breast cancer
J Natl Cancer Inst. 2002 Apr 3;94(7):531-2; author reply 533-4.
Kerenyi N.
No abstract available.
No abstract available.
Neoplasie della mammella
Neoplasie della mammella
Melatonin deficiencies in women
Maturitas. 2002 Apr 15;41 Suppl 1:S85-104.
Rohr UD, Herold J.
In Nordic countries indigenous people suffer less from breast and prostate cancer, winter darkness seems to protect.
Melatonin hypothesis
ht shifts and breast cancer risk: policy implications
J Emerg Nurs. 2002 Apr;28(2):169-71.
Malone RE.
No abstract available.
No abstract available.
Circadian concepts in normal and neoplastic breast
Chronobiol Int. 2002 Jan;19(1):221-35.
Coudert B.
The relationships between melatonin biology and breast cancer require exploration.
Circadian rhythms.
Breast cancer. Night shifts put nurses at risk
Nurs Times. 2001 Oct 25-31;97(43):9.
Kenny C.
No abstract available.
Hormonal manipulations and breast cancer
Obstet Gynecol Surv. 2002 May;57(5):314-23.
Benshushan A, Brzezinski A.
The reader will be able to summarize the effects of estrogen and progestogens on the breast and to list the effects of otherhormonal modulators on thebreast.
Hormones and antihormones
Tumor prevention by 9-cis-retinoic acid in the N-nitroso-N-methylurea model of mammary carcinogenesis is potentiated by the pineal hormone melatonin
Breast Cancer Res Treat. 2002 Mar;72(1):33-43.
Nowfar S, Teplitzky SR, Melancon K, Kiefer TL, Cheng Q, Dwived PD, Bischoff ED, Moro K, Anderson MB, Dai J, Lai L, Yuan L, Hill SM.
Combination of Mlt and 9cRA could be a potentially useful clinical treatment regimen for breast cancer.
9-cis-retinoic acid (9cRA)
Does the negative correlation found in breast cancer patients between plasma melatonin and insulin-like growth factor-I concentrations imply the existence of an additional mechanism of oncostatic melatonin influence involved in defense?
Med Sci Monit. 2002 Jun;8(6):CR457-61.
Kajdaniuk D, Marek B, Kos-Kudła B, Zwirska-Korczala K, Ostrowska Z, Buntner B, Szymszal J.
A negative correlation between plasma melatonin and IGF-I concentrations in patients with neoplastic disease imply an additional defense mechanism based on the oncostatic influence of melatonin.
Insulin-like growth factor-I (IGF-I)
Modulation of intracellular calcium and calmodulin by melatonin in MCF-7 human breast cancer cells
J Pineal Res. 2002 Mar;32(2):112-9.
Dai J, Inscho EW, Yuan L, Hill SM.
Melatonin (10(-7) M) effects on the Ca2+/CaM path-way play a role in the growth-inhibitory on MCF-7 human breast cancer cells.
(Ca2+)/calmodulin (CaM)
Does melatonin induce apoptosis in MCF-7 human breast cancer cells in vitro?
J Pineal Res. 2002 Mar;32(2):90-6.
Cos S, Mediavilla MD, Fernández R, González-Lamuño D, Sánchez-Barceló EJ.
Melatonin (1nM) and dihydroxycholecalciferol (D3) (100 nM) reduce MCF-7 cell proliferation by modulating cell-cycle length through the control of the p53-p21 pathway.
D3/p53/p21
Pagine
